Biomedicines (Dec 2022)

Epidemiological, Clinical, and Genomic Profile in Head and Neck Cancer Patients and Their Families

  • Thiago Celestino Chulam,
  • Fernanda Bernardi Bertonha,
  • Rolando André Rios Villacis,
  • João Gonçalves Filho,
  • Luiz Paulo Kowalski,
  • Silvia Regina Rogatto

DOI
https://doi.org/10.3390/biomedicines10123278
Journal volume & issue
Vol. 10, no. 12
p. 3278

Abstract

Read online

Inherited cancer predisposition genes are described as risk factors in head and neck cancer (HNC) families. To explore the clinical and epidemiological data and their association with a family history of cancer, we recruited 74 patients and 164 relatives affected by cancer. The germline copy number alterations were evaluated in 18 patients using array comparative genomic hybridization. Two or more first-degree relatives with HNC, tobacco-associated tumor sites (lung, esophagus, and pancreas), or other related tumors (breast, colon, kidney, bladder, cervix, stomach carcinomas, and melanoma) were reported in 74 families. Ten index patients had no exposure to any known risk factors. Family members presented tumors of 19 topographies (30 head and neck, 26 breast, 21 colon). In first-degree relatives, siblings were frequently affected by cancer (n = 58, 13 had HNC). Breast cancer (n = 21), HNC (n = 19), and uterine carcinoma (n = 15) were commonly found in first-degree relatives and HNC in second-degree relatives (n = 11). Nineteen germline genomic imbalances were detected in 13 patients; three presented gains of WRD genes. The number of HNC patients, the degree of kinship, and the tumor types detected in each relative support the role of heredity in these families. Germline alterations may potentially contribute to cancer development.

Keywords